KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares OutstandingShort-Term Debt issuances
Ratios

Bristol Myers Squibb (BMY) Leases (2019 - 2025)

Historic Leases for Bristol Myers Squibb (BMY) over the last 7 years, with Q4 2025 value amounting to $1.6 billion.

  • Bristol Myers Squibb's Leases rose 2924.84% to $1.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.6 billion, marking a year-over-year increase of 2924.84%. This contributed to the annual value of $1.6 billion for FY2025, which is 2924.84% up from last year.
  • As of Q4 2025, Bristol Myers Squibb's Leases stood at $1.6 billion, which was up 2924.84% from $1.6 billion recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's Leases peaked at $1.6 billion during Q3 2025, and registered a low of $840.0 million during Q2 2022.
  • Over the past 5 years, Bristol Myers Squibb's median Leases value was $1.2 billion (recorded in 2023), while the average stood at $1.2 billion.
  • Per our database at Business Quant, Bristol Myers Squibb's Leases tumbled by 1650.1% in 2022 and then soared by 5481.31% in 2023.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Leases stood at $919.0 million in 2021, then surged by 32.75% to $1.2 billion in 2022, then grew by 13.93% to $1.4 billion in 2023, then fell by 11.94% to $1.2 billion in 2024, then grew by 29.25% to $1.6 billion in 2025.
  • Its Leases was $1.6 billion in Q4 2025, compared to $1.6 billion in Q3 2025 and $1.3 billion in Q2 2025.